Abstract Satiation, the process that brings eating to an end, and satiety, the state of inhibition over further eating, may be influenced by cholecystokinin (CCK This study was done to see if a low dose of intraduodenal fat induced satiety or satiation and if this effect could be blocked by a CCK receptor antagonist. We have chosen a very low dose of intraduodenal fat (6 g/h intralipid, corresponding to 0-9 kcal/min) to avoid confounding effects
denaily from 1030 until 1300. The subjects received saline (experiments A and B) or loxiglumide (experiment C) a specific CCKreceptor antagonist (10 mg/kg/h) intravenously from 0930 until 1300. At 1200 a meal was served. At regular time intervals hunger feelings were measured using visual analogue scales and food selection lists and plasma CCK was measured by radioimmunoassay. Food intake (mean (SEM)) during intraduodenal fat (206 (35) g) was lower than in the control study (269 (37) g, p=009). Loxiglumide largely prevented the inhibitory effect of intraduodenal fat on food intake (245 (30) g). From 1030 until the meal at 1200 there was a significant satiating effect of intraduodenal fat compared with the control and loxiglumide experiments according to the food selection lists, which was because of the satiating effect for the fat rich items (p<005). Also feelings of fullness were significantly higher during intraduodenal fat than in the control or loxiglumide experiments (p<005). During intraduodenal fat there was a significant increase of plasma CCK from [2] [3] [4] (0.3) to 4*8 (0.4) pM (p<0001). Loxiglumide led to an exaggerated CCK release to a peak concentration of 16 (2.4) 26) participated in this blind, randomised study. Informed consent was obtained from all subjects. The study was approved by the local ethics committee of the University of Leiden. For every experiment each subject presented, after an overnight fast, at 0800 at our research unit where a PVC Freka tube CH8 was introduced through one of the nostrils into the duodenum using a guide wire. After correct positioning as ascertained by fluoroscopy, the guide wire was removed and the tube fixed to the nose. The volunteers accustomed themselvers to the intraduodenal tube for one hour and at 0900 two intravenous catheters were placed into each forearm. From one catheter blood was drawn from 0915 (t=-15) at 15 minutes intervals until the end of the study at 1300 for determination of plasma CCK. The other catheter was used for infusion from 0930 (t=0) until 1300 (t=210).
In a randomised blind investigation three experiments were done with at least one week interval (Table) . At 0930 (t=0) the intravenous infusion of saline (experiments A and B) or loxiglumide 10 mg/kg/h (experiment C) was started. Loxiglumide (CR1505) a potent and specific CCK receptor antagonist" was kindly provided by Rotta Research Laboratories (Monza, Italy). Sterilised and pyrogen free ampules containing 500 mg of loxiglumide (50 mg/ml) were used for infusion after 1:10 dilution. At t=60 the intraduodenal infusion consisting of saline (B) or intralipid 20% (KabiVitrum) (30 ml/h) was started. From t=60 until the end of the infusion at t=210 15 g intralipid was infused into the duodenum.
At 1200 (t= 150) identical sandwiches with lO g margarine and 15 g cheese (3 33 kcal/g) were served and the volunteers were invited to eat until they were fully satiated. The amount eaten was carefully measured as was the duration of the meal. They could drink mineral water (without carbon dioxide) as desired. Basally and every 15 minutes hunger feelings, fullness feelings, prospective feeding intentions, and desire to eat were scored as subjective criteria on 100 mm visual analogue scales as described by Blundell and Silverstone. 3 The subjects were also asked to fill in these hunger scores at home after after the experiment at 1400, 1500, 1600, 1700, and 1800 to assess satiety.
As described by Hill' and modified to Dutch feeding customs, every 30 minutes from t=0 to t=210 a list and photograph of six protein rich, six fat rich, six carbohydrate rich items (each item on the photograph containing 200 kcal), and six low energy items was presented. From each of these 24 items the subjects were asked if they wanted to eat the amount shown, twice the amount, half the amount or nothing, independent of the other items. At each time interval the total amount of caloric items was calculated (half the amount= 112 caloric item, double the amount is 2 caloric items). Also the amount of protein, fat, and carbohydrate items that the subjects wanted to eat was calculated independently.
Plasma CCK was determined in one run using a sensitive and specific radioimmunoassay as has previously been described.4' The intra-assay variation was between 4 6 and 11 501%.
Results are expressed as mean (SEM). Statistical analysis of hunger feelings was performed by calculating the integrated area under the curve followed by Wilcoxon's test for paired results. These non-parametric tests were also used for the other comparisons.
Results

FOOD INTAKE
Food intake was 24% lower during low dose intraduodenal fat (206 (35) g) when compared with saline (269 (37) g), p=0 09). Loxiglumide partially prevented the decrease in food intake during intraduodenal fat to 9% (245 (30) g) (Fig  1) . The differences in food intake, however, did not reach statistical significance.
HUNGER FEELINGS
Before the intralipid infusion no differences in hunger feelings were seen. During the intralipid infusion there was a significant satiating effect compared with the control study (p<005) according to the food selection lists (Fig 2) . This satiating effect of intraduodenal fat was abolished by loxiglumide. If not all the caloric items but only the fatty items are analysed, intraduodenal fat (A) induced also a significant satiety effect compared with saline (B) or loxiglumide (C) (p<005, Fig 2B) . No significant differences were seen for the protein rich or carbohydrate rich items. For hunger feelings, desire to eat, fullness, and prospective feeding intentions no significant differences were found apart from an increase in fullness during intraduodenal fat compared with the control or loxiglumide experiments (p<0 05, Fig 3) . As Figure 3 shows there is also a trend for diminished hunger, desire to eat, and prospective feeding intentions during intraduodenal fat compared with the control and loxiglumide experiment but this did not reach significance when analysing the incremental area under the curve from 60 to 150 minutes. Analysing the period from 120 to 150 minutes separately, however, hunger and desire to eat were significantly lower during intralipid (A) compared with the control (B) or loxiglumide experiment (C) (p<005). When analysing the differences between t= 150 (start of the meal) and t=60 minutes (start of the intralipid infusion) a significant difference in hunger desire to eat, prospective feeding and fullness was seen between the intralipid (A) and control experiment (B). With that method, however, no significant differences were seen between the intralipid (A) and loxiglumide (C) experiment although there was a tendency towards less satiety with loxiglumide. There were no differences in hunger feelings in the hours after the experiment. No adverse effects were reported during any test. 
CCK
Mean basal plasma CCK was not significantly different during the three experiments (respectively 2-6(0 1),2-7(0-3), and 2-6(0-2) pM during experiments A, B, and C). During the intraduodenal fat infusion there was a significant increase of plasma CCK from 2-4 (0 3 at t=60 min to 4-8 (0-4) pM at t=150 min (start of meal, p<0 001; Fig 4) . In the loxiglumide experiment (C) this CCK release was exaggerated to 16-5 (2-4) pM. After the meal there was a further increase in plasma CCK to 23-2 (1-8) pM (Fig 4, p<0-01 ).
In the control experiment plasma CCK was not changed until the meal was eaten.
Discussion
In rats, it has been shown that intraduodenal oleic acid induces CCK release and feeding depression whereas intraduodenal triolein does not induce CCK release or feeding depression.4243 This finding suggests that fat affects feeding by releasing CCK. In our experiments we have shown that with an intraduodenal infusion of only 6 g intralipid/h we could induce a significant CCK increase leading to plasma concentrations previously found after a regular meal.3 This intraduodenal fat infusion induced a significant (subjective) satiety effect and caused a decrease in food intake of 24% compared with the control experiment. The specific CCK A receptor antagonist prevented this satiety effect and partially reversed the decrease in food intake. Loxiglumide alone did not have an effect on food intake in humans."
The only other study on the effect of fat on plasma CCK and satiety used a much larger amount of fat.36 In that study Drewe et 16 27 We have also now found in humans that endogenous CCK plays a key part in the decreased food intake and increased satiety when introduodenal fat is given. During a low dose of intraduodenal intralipid the subjects wanted to eat significantly less calories, especially fatty items, compared with saline. This selective effect of fat infusion on the choice of fat is important theoretically and practically because it points to a feedback mechanism from physiology (detection of fat) to behaviour (food selection). Blockade other studies where CCK receptor antagonists have been given.5" It is possible that this augmented CCK release during loxiglumide is partly explained by a diminished bile acid concentration in the lumen of the proximal small intestine because of diminished gall bladder emptying and partly by a diminished local release of somatostatin in the intestinal mucosa. 52 In conclusion, this study shows that in humans a low dose of intraduodenal fat increases satiety and satiation mainly through the effect of CCK. 
